Breaking News

Making productivity sustainable with Pharma 4.0

David Bean, Solutions Group Manager at Mitsubishi Electric looks at how industrial automation can improve the environmental footprint of pharmaceut...

UK Chemists cut energy consumption in half

"As a department we are constantly exploring ways to cut down on our electricity usage. We chose to standardise on DrySyn MULTI heating blocks as t...

Recipharm extends commercial manufacturing for RedHill’s drug

Talicia is eligible for eight years of US market exclusivity under QIDP designation and its patent protection extends at least until 2034

Modernising therapeutic cell production

Science-based innovation to manufacture high quality cells challenges central dogma and terminology

CordenPharma joins SBTi to counter greenhouse gases

To join the initiative, CordenPharma has committed to evaluating and developing over the next year science-based greenhouse gas emission reduction...

Lonza invests $21.3m in Chinese facility

Expanded capacity in Nansha will allow for mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial pro...

Handheld Raman analysers give a helping hand in quality control

Raman spectroscopy is a simple and robust method that can be used to analyse the molecular composition of solid, liquid or gaseous samples. This po...

Manufacturing Chemist LIVE 2023: Expert Speakers Wanted

Previous years have included presentations from the likes of NASA, AstraZeneca, GSK, CMAC and we are now looking for 2023's experts

Catalent expands clinical supply facility

The completion will be marked by two customer events, on December 1 and December 6

Quotient Sciences announces manufacturing and clinical testing partnership

Emplicure is developing EMPLI03 as an oral buccal tablet with extended-release properties intended for the treatment of moderate to severe pain

Outsourced lateral flow manufacturing: stability and security during uncertainty

In business, as with life itself, the COVID-19 pandemic brought uncertainty. Since then, geopolitical events have meant that businesses are finding...

Cell and gene therapies: on the brink of commercialisation

With their one-and-done potential and pinpoint targeting capability, cell and gene therapies (CGTs) offer huge promise in the fight against a range...

Denny Bros completes final phase of solar panel investment

“We were committed to the investment even before the recent astronomical rises in energy costs"

Famar and IMA Active: partners in excellence

Michele Vite (MV), Head of Production, and Enrico Russo (ER), Head of Engineering and Maintenance, at Famar Italia, talk to Dr Kevin Robinson (KSR)...

CPI opens medicine manufacturing centre in Scotland

The centre is forecast to generate £200 million in advanced technologies over the first 5 years and will deliver a tangible impact for businesses

Industry first experiments break the mould for the VHP decontamination of RTU vials

Markus Heinz, Product Manager, Vial Liquid and Powder at Syntegon, and Fabio Bertacchini, Product Management Director at Stevanato Group, present n...